悦康药业(688658.SH)上半年净亏损9882.91万元

Core Insights - The company reported a significant decline in revenue for the first half of 2025, with total revenue reaching 1.167 billion, representing a year-on-year decrease of 40.14% [1] - The net profit attributable to the parent company was negative at 98.8291 million, compared to a profit of 119 million in the same period last year [1] - The non-recurring net profit attributable to the parent company also showed a decline, amounting to negative 108 million, down from 117 million in the previous year [1]